Afatinib
LUX-Lung 7 Update: Trend for OS Benefit for Afatinib
Copenhagen, Denmark—Updated results from the Phase IIb LUX-Lung 7 trial of afatinib versus gefitinib were ...
FEBRUARY 3, 2017
Gilotrif Approved for Lung Cancer
The drug is already approved in more than 60 countries to treat patients with distinct types of epidermal growth ...
APRIL 17, 2016
Load more